Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04751864 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04751864 · ClinicalTrials.gov record · last posted 2021-02-12

Brain Stimulation & Generalized Anxiety Study

StatusActive, Not Recruiting
PhasePhase 4
SponsorProofPilot
Started2020-10-15
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 12, 2021 (before its estimated March 31, 2021 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator (CES) Device on Generalized Anxiety Disorder using two (2) 20-minute per day treatment sessions over eight weeks.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2021-02-09. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-07-29
Status change Active, Not Recruiting→Completedv1
Trial Details
NCT Number NCT04751864
Lead Sponsor ProofPilot
Collaborators: Fisher Wallace
Conditions Anxiety, Generalized Anxiety Disorder, Generalized Anxiety
Enrollment 150 participants
Start Date 2020-10-15
Primary Completion 2021-03-31 (estimated)
Study Completion 2021-06-21 (estimated)
Updated on ClinicalTrials.gov 2021-02-12